Life Science Recruitment

"Abbott has received Europe’s CE mark for the first dual-analyte sensor that can measure both glucose and ketones, the company said Wednesday."

Abbott receives CE mark for dual glucose-ketone sensor Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

Targeted protein degradation is moving beyond the hype — the real progress now comes down to disciplined ex*****on, early decision-making, and integrated discovery from the start.

Targeted Protein Degradation and Novel Modalities: Getting on the Frontline Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule programs were built around inhibition. | Explore how targeted protein degradation is reshaping drug discovery, enabling new approaches for difficult targets and advancing nov...

Wishing the very best of luck to all Finalists for the 2026 Women in Pharma Awards!

Women in Pharma Awards 2026 - Shortlist Launched under the auspices of the industry leading Pharma Industry Awards, this event is committed to recognising the contributions of women professionals, teams, and projects within the pharmaceutical industry, highlighting their originality, innovation, and excellence. Since its inception in 2015...

"Indeed’s research found that several major European markets are likely to miss targets set out by the upcoming EU Pay Transparency Directive deadline, which states that by June 2026, employers must have created an environment in which the discussion of pay is not shrouded in secrecy or otherwise restricted. "

Major European markets behind on salary transparency, finds report Ahead of the deadline for the EU Pay Transparency Directive, major European markets were found to be lagging and could miss the June target.

"A new all-island research programme will support Irish-US collaboration between researchers, innovators and industry partners through a $20m investment." https://www.siliconrepublic.com/innovation/us-irish-trilateral-research-programme-to-receive-20mhttps://app.socialpilot.co/launchpad #

LaunchPad programme targeting digital business entrepreneurs - Start-ups | siliconrepublic.com - Ireland's Technology News Service A new programme that is targeted at emerging start-up entrepreneurs is now accepting applications.

"‘Significant’ patient population unresponsive to existing schizophrenia treatments, highlighting ‘major unmet clinical need’, according to PhD researcher Keelin Harrison."

Probing the link between inflammation and schizophrenia Keelin Harrison is a PhD student researching the role of neuroinflammation in the pathology of schizophrenia.

"Boston Scientific Corporation (NYSE: BSX) – a global leader in medical device technology – today announced a €75 million investment in its Galway site, including the expansion of its research and development (R&D) capabilities, further strengthening its role as a global centre for cardiovascular innovation."

Boston Scientific announces €75 million investment to expand R&D capabilities in Galway Stay informed about the latest press releases, news, announcements, articles, and blog posts from IDA Ireland. Explore insights on FDI in Ireland to stay ahead.

"Ireland has evolved into one of the world’s most critical locations for the global Pharmaceutical Industry. Today, with more than 90 FDA-approved facilities, 50,000 people employed in the sector, and more than $133 billion in annual pharmaceutical exports, the country combines stability, world-class talent and an integrated global supply chain"

Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry | PharmExec Ireland has built a track record of regulatory excellence that few regions have matched.

Dupixent® (dupilumab) Approved in the EU!

Access Denied

Big progress in heart failure treatment- innovation in cardiovascular care continues to move forward.

Bayer wins MHRA approval for Kerendia in heart failure - PharmaTimes New authorisation offers additional option for patients with lvef ≥40%